tetano
Editor, Senior Moderator
Emerg Infect Dis. 2012 Feb;18(2):308-311. doi: 10.3201/eid1802.111466.
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010-11.
Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM; for the US Antiviral Resistance Surveillance Working Group.
Abstract
During October 2010-July 2011, 1.0% of pandemic (H1N1) 2009 viruses in the United States were oseltamivir resistant, compared with 0.5% during the 2009-10 influenza season. Of resistant viruses from 2010-11 and 2009-10, 26% and 89%, respectively, were from persons exposed to oseltamivir before specimen collection. Findings suggest limited community transmission of oseltamivir-resistant virus.
PMID:
22305467
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22305467
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010-11.
Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM; for the US Antiviral Resistance Surveillance Working Group.
Abstract
During October 2010-July 2011, 1.0% of pandemic (H1N1) 2009 viruses in the United States were oseltamivir resistant, compared with 0.5% during the 2009-10 influenza season. Of resistant viruses from 2010-11 and 2009-10, 26% and 89%, respectively, were from persons exposed to oseltamivir before specimen collection. Findings suggest limited community transmission of oseltamivir-resistant virus.
PMID:
22305467
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22305467